The attorney general of Connecticut is seeking information from Novartis about an alleged shortage in the company's supply of seasonal-flu vaccine to certain health-care organizations. Connecticut Attorney General Richard Blumenthal is probing Novartis' supply contract with Visiting Nurse Associations of America.
Novartis had contracted to provide 350,000 doses of seasonal flu vaccine to the nurse groups by Sept. 30, but Novartis recently notified the association that only 100,000 doses would be delivered, according to association spokeswoman Emily Swanson.
Novartis said Thursday in a written statement the company switched to production of swine-flu in late July, and didn't have the usual window of opportunity to make up for a lower-than-projected amount of seasonal-flu vaccine. Novartis said it had to reduce its seasonal-flu vaccine orders by 10 percent.
Novartis didn't address whether it had pledged to deliver 350,000 doses.